Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA Appears To Have Avoided Shutdown-Related ANDA Bolus

Feb 22 2019

• By Derrick Gingery

FDA entrance sign 2016

Related Content

ANDA Sponsors Face Tight Controls On Meetings With US FDA After CR Letters

Dec 12 2018

ANDA Avalanche: How Will FDA Deal With The 600 Received This Month?

Jun 30 2014

Shutdown Week Four: FDA Maintains Pre-Shutdown Output Pace In Some Cases

Jan 14 2019

FDA's Post-Shutdown ANDA Bolus Could Be Massive

Jan 25 2019

Additional Topics

United States Generic Drugs Review Pathway Drug Review Regulation FDA BioPharmaceutical

More from Generics

More from Biosimilars & Generics

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window